Modulation of glucose-6-phosphate dehydrogenase activity and expression is associated with aryl hydrocarbon resistance in vitro.
The mutagenic effect of environmental carcinogens has been well documented in animal models and in human studies but the mechanisms involved in preventing carcinogen insult have not been fully elucidated. In this study we examined the molecular and biochemical changes associated with carcinogen resistance in a series of aryl hydrocarbon-resistant MCF-7 cell lines developed by exposure to benzo[a]pyrene (BP). The cell lines were designated as AH(R40), AH(R100), and AH(R200) to denote their increasing fold resistance to BP compared with wild type cells. These cell lines were also resistant to another aryl hydrocarbon (AH), dimethylbenz[a]anthracene, but not to pleiotropic drugs (doxorubicin, vinblastine, and taxol). The resistant cell lines showed an increase in the level of the primary intracellular antioxidant, reduced glutathione, corresponding to increasing AH resistance. However, there was no change in glutathione reductase activity. The generation of reduced glutathione requires NADPH, and we therefore examined the activity and expression of the rate-limiting enzyme in NADPH production, glucose-6-phosphate dehydrogenase (G6PD). An increase in G6PD specific activity was associated with increasing aryl hydrocarbon resistance. This was due to an increased expression of G6PD in resistant cells, which was demonstrated by increases in both protein and mRNA levels. However, there was no increase in the transcription rate of G6PD in the resistant cell lines, indicating that the increase G6PD expression is due to a post-transcriptional modulation, which was confirmed by actinomycin D chase experiments. These results demonstrate that modulation of G6PD expression and activity is an important mechanism in AH resistance.
Yeh
G C
GC
Cellular Defense and Carcinogenesis Section, Basic Research Laboratory, NCI at Frederick, National Institutes of Health, Frederick, Maryland 21702, USA. yeh@ncifcrf.gov
Daschner
P J
PJ
Lopaczynska
J
J
MacDonald
C J
CJ
Ciolino
H P
HP
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000633:toxicity*; D001564:Benzo(a)pyrene / Q000633:toxicity*; D002273:Carcinogens / Q000633:toxicity*; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D005954:Glucosephosphate Dehydrogenase / Q000235:genetics / Q000378:metabolism*; D005978:Glutathione / Q000032:analysis; D006801:Humans; D008658:Inactivation, Metabolic; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger / Q000032:analysis; D014407:Tumor Cells, Cultured
D002273:Carcinogens; D012333:RNA, Messenger; D001564:Benzo(a)pyrene; D015127:9,10-Dimethyl-1,2-benzanthracene; D005954:Glucosephosphate Dehydrogenase; D005978:Glutathione